Dendritic Cells Take up and Present Antigens from Viable and Apoptotic Polymorphonuclear Leukocytes

• Carlos Alfaro,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Natalia Suarez,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Carmen Oñate,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Jose L. Perez-Gracia,

  Affiliation Medical Oncology Department, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain

  ⨯
• Ivan Martinez-Forero,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Sandra Hervas-Stubbs,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Inmaculada Rodriguez,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Guiomar Perez,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Elixabet Bolaños,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Asis Palazon,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Miguel Fernandez de Sanmamed,

  Affiliations Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain, Medical Oncology Department, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain

  ⨯
• Aizea Morales-Kastresana,

  Affiliation Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain

  ⨯
• Alvaro Gonzalez,

  Affiliation Biochemistry Department, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain

  ⨯
• Ignacio Melero

  * E-mail: imelero@unav.es

  Affiliations Gene Therapy Unit, CIMA, Universidad de Navarra, Pamplona, Spain, Medical Oncology Department, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain

  ⨯